Regulatory update on red yeast rice monacolins in food supplements. The European Commission is evaluating a possible total ban, with transitional periods of 6 or 12 months. Analysis of timelines, regulatory implications, EFSA’s role and impact on nutraceutical companies. Red yeast rice monacolins are once again at the center of the European regulatory debate. In…
A crucial EU ruling (Case C-589/23) redefines the distinction between medical devices and medicinal products, clarifying when a substance—like D-mannose—exerts a pharmacological action under Directive 2001/83/EC The boundary between “medicinal product” and “medical device” is often subject to divergent interpretations in European markets, especially for so-called borderline products that do not clearly fall under one…
Thank You for Visiting Our Stand The participation of Gruppo Farmaimpresa at Vitafoods Europe 2025, held from May 20 to 22 at Fira Barcelona, has successfully come to an end. This event is one of the most important international gatherings for the nutraceutical industry, and we were proud to share our latest innovations in the…
Looking to simplify the market launch of medical devices, food supplements, and cosmetics? With Gruppo FarmaImpresa, it’s possible Having an innovative idea or a high-quality product is not enough for medical devices, food supplements, or cosmetics. To successfully reach the market, companies must navigate a complex and highly regulated path. In Europe, this process revolves…
How Amla Oil Extract Can Improve General Well-being Amla, also known as Indian gooseberry (Phyllanthus emblica), has been celebrated for centuries in traditional medicine for its numerous health benefits. Over time, scientific research has confirmed many of these benefits, making it a key ingredient in modern nutraceuticals. This small, tangy fruit is packed with vitamins,…
Conference “Dietary Supplements: Market and Development” – Participation of Farmaimpresa and Meetings with Prominent Italian Politicians On July 4, 2024, the conference “Dietary Supplements: Market Analyzed and Development Prospects in the Current European Regulatory Framework” was held in the Sala del Refettorio at Palazzo San Macuto. It was a privilege for Gruppo FarmaImpresa to be…
Ministry of Health: Adherence to PagoPA and Telematic Payments for Food Services The Ministry of Health, through Office IV with note 0049139-22/12/2023-DGISAN-MDS-P, has communicated its adherence to the national PagoPA platform for the telematic payment of fees related to services offered by the Department. This step has been taken in accordance with the Digital Administration…
Online pharmacy market shows growth, in values, over the same period of 2022 The online pharmacy market also shows after two months sales growth over the same period in 2022, but only in values, because in volumes the difference over the past year still remains negative. This is according to the report with which Iqvia…
The online pharmacy market recovers the gap on the previous year with +3% in values In a month and a half, the online pharmacy and parapharmacy market has already recovered the gap on the previous year and is traveling with +3% compared to the same period in 2022. Only in values, however, because in packages…
Disputed the presence on the market of food supplements containing bud derivatives of Viburnun Lantana L. Preparations based on buds of Viburnun Lantana L., in the context of the DM 10/08/2018 on the “Regulation of the use in food supplements of plant substances and preparations,” do not appear among the parts of the plant that…